SGLT2 Inhibitors Improve Cardiovascular Outcomes Across Grou

A comprehensive meta-analysis finds cardiovascular improvement across age, sex, and race/ethnicity for high-risk individuals with type 2 diabetes and other CVD risk factors.

Related Keywords

Illinois , United States , Southern Illinois University , Springfield , Mukul Bhattarai , Southern Illinois University School Of Medicine , , Southern Illinois University School , Consistent Cardiovascular Benefits , Seen Across Age , Ethnicity Subgroups , Heart Failure , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Ami , Acute Myocardial Infarction , Myocardial Infarction , Acute Coronary Syndrome Acs , Cute Coronary Syndrome , Cs , Atherosclerotic Heart Disease , Therosclerotic Cardiovasc ,